| scholarly article | Q13442814 |
| P356 | DOI | 10.1158/1535-7163.MCT-04-0277 |
| P698 | PubMed publication ID | 15827331 |
| P50 | author | Shigeki Takemoto | Q47696506 |
| P2093 | author name string | Yang Yang | |
| H Phillip Koeffler | |||
| Takayuki Ikezoe | |||
| Hirokuni Taguchi | |||
| Kazuto Togitani | |||
| Kentaro Bandobashi | |||
| Tsuyako Saito | |||
| Hisanori Machida | |||
| P2860 | cites work | Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera | Q34276501 |
| P433 | issue | 4 | |
| P921 | main subject | NF-κB | Q411114 |
| P304 | page(s) | 578-586 | |
| P577 | publication date | 2005-04-01 | |
| P1433 | published in | Molecular Cancer Therapeutics | Q2363144 |
| P1476 | title | Oridonin, a diterpenoid purified from Rabdosia rubescens, inhibits the proliferation of cells from lymphoid malignancies in association with blockade of the NF-kappa B signal pathways | |
| P478 | volume | 4 |
| Q39855631 | A novel treatment strategy targeting polo-like kinase 1 in hematological malignancies |
| Q35143916 | Anti-cancer natural products isolated from chinese medicinal herbs |
| Q64889831 | Anticancer Activity and Underlying Mechanism of Phytochemicals against Multiple Myeloma. |
| Q35415849 | Bharangin, a diterpenoid quinonemethide, abolishes constitutive and inducible nuclear factor-κB (NF-κB) activation by modifying p65 on cysteine 38 residue and reducing inhibitor of nuclear factor-κB α kinase activation, leading to suppression of NF- |
| Q39651374 | Combined activity of oridonin and wogonin in advanced-stage ovarian cancer cells: sensitivity of ovarian cancer cells to phyto-active chemicals |
| Q35996703 | Compromising σ-1 receptors at the endoplasmic reticulum render cytotoxicity to physiologically relevant concentrations of dopamine in a nuclear factor-κB/Bcl-2-dependent mechanism: potential relevance to Parkinson's disease |
| Q37855820 | Direct Rel/NF-κB inhibitors: structural basis for mechanism of action |
| Q28387804 | Discovery and development of natural product oridonin-inspired anticancer agents |
| Q27020978 | Disruption of Bcl-2 and Bcl-xL by viral proteins as a possible cause of cancer |
| Q40023730 | Down-regulation of androgen-receptor and PSA by phytochemicals |
| Q54246268 | Effects of Oridonin on growth performance and oxidative stress in broilers challenged with lipopolysaccharide. |
| Q40266774 | Eriocalyxin B induces apoptosis of t(8;21) leukemia cells through NF-kappaB and MAPK signaling pathways and triggers degradation of AML1-ETO oncoprotein in a caspase-3-dependent manner. |
| Q45406431 | Fludarabine induces apoptosis of human T-cell leukemia virus type 1-infected T cells via inhibition of the nuclear factor-kappaB signal pathway |
| Q41947262 | Genomic and in vivo evidence of synergy of a herbal extract compared to its most active ingredient: Rabdosia rubescens vs. oridonin |
| Q38724028 | Geridonin, a novel derivative of oridonin, inhibits proliferation of MGC 803 cells both in vitro and in vivo through elevating the intracellular ROS. |
| Q38816390 | Henrin A: A New Anti-HIV Ent-Kaurane Diterpene from Pteris henryi |
| Q43779868 | IL-1β inhibits self-renewal capacity of dormant CD34⁺/CD38⁻ acute myelogenous leukemia cells in vitro and in vivo |
| Q54628943 | Inhibition of signal transducer and activator of transcription 5 by the inhibitor of janus kinases stimulates dormant human leukemia CD34+ /CD38- cells and sensitizes them to antileukemia agents. |
| Q37459881 | Injury-induced platelet-derived growth factor receptor-alpha expression mediated by interleukin-1beta (IL-1beta) release and cooperative transactivation by NF-kappaB and ATF-4: IL-1beta facilitates HDAC-1/2 dissociation from promoter. |
| Q37191038 | Investigation of the anti‑asthmatic activity of Oridonin on a mouse model of asthma |
| Q37941882 | Luminescent detection of DNA-binding proteins |
| Q80638868 | Melissoidesin G, a diterpenoid purified from Isodon melissoides, induces leukemic-cell apoptosis through induction of redox imbalance and exhibits synergy with other anticancer agents |
| Q26796359 | Molecular Insight in the Multifunctional Effects of Oridonin |
| Q37008647 | NF-kappaB in pathogenesis and treatment of adult T-cell leukemia/lymphoma |
| Q61453712 | Natural Compound Oridonin Inhibits Endotoxin-Induced Inflammatory Response of Activated Hepatic Stellate Cells |
| Q64084819 | Natural Diterpenoid Oridonin Ameliorates Experimental Autoimmune Neuritis by Promoting Anti-inflammatory Macrophages Through Blocking Notch Pathway |
| Q38632963 | Natural products against hematological malignancies and identification of their targets |
| Q58784523 | Oridonin Enhances Radiation-Induced Cell Death by Promoting DNA Damage in Non-Small Cell Lung Cancer Cells |
| Q37557568 | Oridonin ameliorates neuropathological changes and behavioural deficits in a mouse model of cerebral amyloidosis |
| Q40183990 | Oridonin induced apoptosis through Akt and MAPKs signaling pathways in human osteosarcoma cells |
| Q35127404 | Oridonin induces apoptosis and cell cycle arrest of gallbladder cancer cells via the mitochondrial pathway |
| Q33740026 | Oridonin induces apoptosis and senescence in colorectal cancer cells by increasing histone hyperacetylation and regulation of p16, p21, p27 and c-myc |
| Q33303792 | Oridonin induces apoptosis via PI3K/Akt pathway in cervical carcinoma HeLa cell line |
| Q37745233 | Oridonin induces autophagy via inhibition of glucose metabolism in p53-mutated colorectal cancer cells |
| Q35491865 | Oridonin stabilizes retinoic acid receptor alpha through ROS-activated NF-κB signaling |
| Q47128815 | Oridonin synergistically enhances JQ1-triggered apoptosis in hepatocellular cancer cells through mitochondrial pathway |
| Q34308761 | Oridonin: targeting programmed cell death pathways as an anti-tumour agent |
| Q47400524 | Phytotherapeutics Oridonin and Ponicidin show Additive Effects Combined with Irradiation in Pancreatic Cancer in Vitro |
| Q90704384 | Protective Effects of Oridonin on Acute Liver Injury via Impeding Posttranslational Modifications of Interleukin-1 Receptor-Associated Kinase 4 (IRAK4) in the Toll-Like Receptor 4 (TLR4) Signaling Pathway |
| Q38831840 | Reactive oxygen species mediate oridonin-induced apoptosis through DNA damage response and activation of JNK pathway in diffuse large B cell lymphoma |
| Q38094980 | Recent advances in the molecular basis of anti-neoplastic mechanisms of oridonin |
| Q37084417 | Role of LM23 in cell proliferation and apoptosis and its expression during the testis development |
| Q53031544 | Role of NF-κB-dependent signaling in the growth capacity of mesenchymal progenitor cells under the influence of basic fibroblast growth factor. |
| Q43947918 | Role of NF-κB-dependent signaling in the realization of growth potential of mesenchymal progenitor cells in vitro |
| Q28485333 | Selection for high oridonin yield in the Chinese medicinal plant Isodon (Lamiaceae) using a combined phylogenetics and population genetics approach |
| Q39608525 | Sensitization to TRAIL-induced apoptosis in human neuroblastoma SK-N-AS cells by NF-κB inhibitors is dependent on reactive oxygen species (ROS). |
| Q33613556 | Sigma-1 receptors regulate Bcl-2 expression by reactive oxygen species-dependent transcriptional regulation of nuclear factor kappaB |
| Q36208548 | Specific deletion of TRAF3 in B lymphocytes leads to B-lymphoma development in mice. |
| Q41343608 | Synergistic suppression of t(8;21)-positive leukemia cell growth by combining oridonin and MAPK1/ERK2 inhibitors |
| Q52716625 | Targeting AKT with oridonin inhibits growth of esophageal squamous cell carcinoma in vitro and patient derived xenografts in vivo. |
| Q37945228 | Targeting HTLV-1 activation of NFκB in mouse models and ATLL patients |
| Q38054798 | Terpenoids: natural products for cancer therapy |
| Q61947589 | Therapeutic Potential of Oridonin and Its Analogs: From Anticancer and Antiinflammation to Neuroprotection |
| Q34315800 | ent-Kaurane-based regio- and stereoselective inverse electron demand hetero-Diels-Alder reactions: synthesis of dihydropyran-fused diterpenoids |
| Q39762903 | p53 is critical for the Aurora B kinase inhibitor-mediated apoptosis in acute myelogenous leukemia cells |
Search more.